A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis
Clinical trial NCT03706040 · COMPLETED
Trial details
- NCT number
- NCT03706040
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-27
- Primary completion
- 2020-10-28
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.